1. DNA Repair Function: BRCA2 plays a crucial role in repairing damaged DNA through a process called homologous recombination (HR). HR repairs double-strand DNA breaks by using a homologous template, usually the undamaged sister chromatid, as a reference to restore the damaged sequence.
2. Involvement in Cell Cycle Checkpoint Control: BRCA2 also plays a critical role in cell cycle checkpoint control. Cell cycle checkpoints ensure that damaged DNA is repaired before allowing the cell to progress to the next stage of the cell cycle. BRCA2 is involved in activating the checkpoint response and preventing cell division when DNA damage is detected.
3. Maintaining Genome Stability: BRCA2 is involved in maintaining the overall stability of the genome. It helps prevent chromosomal rearrangements, deletions, and other genetic alterations that can lead to cancer development.
4. Mutations Lead to Dysfunctional Protein: Mutations in the BRCA2 gene can result in the production of a dysfunctional BRCA2 protein, compromising its ability to carry out its essential functions effectively. This can lead to an accumulation of DNA damage and increased genomic instability, eventually increasing the risk of cancer development.
5. Inheritance Pattern: BRCA2 mutations can be inherited in an autosomal dominant manner, meaning that inheriting a single copy of the mutated gene from either parent is sufficient to confer an increased cancer risk. This inheritance pattern explains why certain families have a higher prevalence of breast and ovarian cancers.
6. Cancer Risk Estimates: Women who carry a harmful BRCA2 mutation have an estimated lifetime risk of developing breast cancer of up to 85% and an estimated lifetime risk of developing ovarian cancer of up to 40%. Men with BRCA2 mutations also have an increased risk of developing certain types of cancer, including breast, prostate, and pancreatic cancers.
7. Genetic Testing and Preventive Measures: Knowing about a BRCA2 mutation allows individuals and their healthcare providers to take proactive steps to manage the associated cancer risks. Regular screening, risk-reducing surgeries, and preventive measures can be implemented to reduce the likelihood of cancer development or detect it at an early, more treatable stage.
In summary, BRCA2 is linked to cancer risk because of its critical role in DNA damage repair and maintaining genome stability. Mutations in this gene can lead to dysfunctional protein function, accumulate DNA damage, and increase genomic instability, all of which contribute to the elevated risk of developing certain types of cancer, particularly breast and ovarian cancers. Genetic testing for BRCA2 mutations can provide valuable information for individuals with a family history of these cancers, allowing for personalized risk management strategies.
